Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
Viroj Wiwanitkit1–31Wiwanitkit House, Bang Khae, Bangkok, Thailand; 2Hainan Medical University, Haikou, Hainan, People's Republic of China; 3Joseph Ayo Babalola University, Ikeji-Arakeji, Osun State, NigeriaAbstract: Leishmaniasis is an important vector-borne disease, and i...
Main Author: | Wiwanitkit V |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-06-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/interest-in-paromomycin-for-the-treatment-of-visceral-leishmaniasis-ka-a10203 |
Similar Items
-
Visceral Leishmaniasis (Kala-Azar) and Pregnancy
by: Ernesto Antonio Figueiró-Filho, et al.
Published: (2004-01-01) -
Easy Test for Visceral Leishmaniasis and Post–Kala-azar Dermal Leishmaniasis
by: Samiran Saha, et al.
Published: (2011-07-01) -
Urbanization of visceral leishmaniasis (kala-azar) in Fortaleza, Ceará, Brazil Urbanización de la leishmaniasis visceral (kala-azar) en Fortaleza, Ceará, Brasil
by: Polianna Lemos Moura Moreira Albuquerque, et al.
Published: (2009-10-01) -
Optimal control of visceral, cutaneous and post kala-azar leishmaniasis
by: M. Zamir, et al.
Published: (2020-10-01) -
Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
by: Sankha Koley, et al.
Published: (2013-01-01)